OSU MedNet21

This webcast will discuss Updates in Nephrology. Many new developments in the management of chronic kidney disease have occurred in the past 5 years and most physicians did not learn about these new concepts during medical school and residency. This webcast will help improve outcomes of patients with chronic kidney disease by educating physicians about new concepts in management.

Link to transcript

Welcome to the new home for our OSU MedNet21 podcast series. When our new season starts on September 8th, all new podcast episodes will appear here. You can find a link to the upcoming schedule in the podcast summary.

Link to transcript

Today on MedNet21, we’re going to discuss Infertility. Listeners will learn important historical factors related to infertility, understand testing performed and be exposed to basic infertility treatment.

Link to transcript

Today on MedNet21, we’re going to discuss Lymphoma. Today on MedNet21, we’re going to discuss Lymphoma. Learners should be able to identify risk factors for inferior outcomes in diffuse large B-cell lymphoma. Learners should be aware of treatment options for diffuse large B-cell lymphoma. Program will share approach to classifying, diagnosing, and managing patients with indolent B-cell lymphoma.

Link to transcript

Today on MedNet21, we’re going to discuss Addiction, Stigma, & Person-First Language. This presentation reviews the neurobiology of addiction and explores the impact of addiction stigma on patients with substance use disorders. Together, we will describe the basic neurobiology of addiction and apply this understanding of neurobiology to check biases toward individuals with addiction. Additionally, we will discuss ways to reduce addiction stigma through clinically accurate person-first language.

Link to transcript

Today on MedNet21, we’re going to discuss Prostate Cancer Screening. This presentation will discuss what we have learned about PSA screening in the last 20 years. This includes the proposed benefits, harms, and national controversies. We will conclude with a practical approach to applying PSA screening in a primary care setting.

Link to transcript

Today on MedNet21, we’re going to discuss Leukemia. In this talk we will cover the presenting signs and symptoms of CML as well as Acute Leukemias, with a focus on differentiating these two broad categories by history, exam and laboratory abnormalities. We will also review specific diagnostic tests, broad treatments as well as expected side effects.

Link to transcript

Today on MedNet21, we’re going to discuss COVID-19 Impact on Pediatrics. Viewer’s will learn about social emotional wellbeing of children and adolescents during the COVID-19 pandemic. Viewers will learn about how quality of life and loneliness was affected over the first year of the pandemic. Viewers will also learn about facilitators and barriers to maintaining quality of life and social/emotional well-being for children during and beyond the pandemic. 

Learners will know about acute COVID symptoms and learn about post COVID symptoms that are prevalent in the adolescent population. They will learn about how we are managing these symptoms in the pediatric pulmonary clinic and what other subspecialties are also helpful for these patients.

Link to transcript

Today on MedNet21, we’re going to discuss Value Based Care and Reimbursement. Learner’s should expect to learn about the recent trend of retail and other for-profit entities moving into the value-based primary care space and what that might mean for the industry as well as their individual practice. We will also focus on the tenets of value-based care, how to be successful, and future directions we see in the industry.

Link to transcript

Today on MedNet21, we’re going to discuss COVID-19 Vaccine Updates. Learners will review the currently available COVID 19 vaccines, review safety and efficacy for vaccine use, and review recommendations for vaccination based upon age group and immune status. This presentation focuses on providing an update on COVID-19 vaccination effectiveness and safety data as well as summarizing the most recent FDA and CDC vaccine recommendations.

Link to transcript